209 related articles for article (PubMed ID: 21503209)
1. Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention.
Sterner G; Nyman U
Libyan J Med; 2007 Sep; 2(3):118-24. PubMed ID: 21503209
[TBL] [Abstract][Full Text] [Related]
2. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
3. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
4. Reducing the risks for contrast-induced nephropathy.
Stacul F
Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S12-8. PubMed ID: 16419278
[TBL] [Abstract][Full Text] [Related]
5. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
[TBL] [Abstract][Full Text] [Related]
6. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Thomsen HS; Morcos SK
Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
[TBL] [Abstract][Full Text] [Related]
7. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
[TBL] [Abstract][Full Text] [Related]
8. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
9. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
[TBL] [Abstract][Full Text] [Related]
10. Current concepts of contrast-induced nephropathy: a brief review.
Chang CF; Lin CC
J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
[TBL] [Abstract][Full Text] [Related]
11. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
12. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.
Gupta RK; Bang TJ
Semin Intervent Radiol; 2010 Dec; 27(4):348-59. PubMed ID: 22550376
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
15. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
Nyman U; Almén T; Jacobsson B; Aspelin P
Eur Radiol; 2012 Jun; 22(6):1366-71. PubMed ID: 22307815
[TBL] [Abstract][Full Text] [Related]
16. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
17. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
18. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
19. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
20. [Contrast-induced nephropathy].
Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]